ITOS Insider Trading Activity and SEC Form 4 Filings
ITOS insider trading summary
No open-market insider purchases or sales of iTeos Therapeutics, Inc. (ITOS) have been reported on SEC Form 4 in the past 12 months.
Latest ITOS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 10, 2025 | Michel Detheux | Chief Executive Officer | Sell | $440K (43,883 @ $10.02) |
| Jun 10, 2025 | Michel Detheux | Chief Executive Officer | Sell | $84K (8,400 @ $10.02) |
| Jun 9, 2025 | Michel Detheux | Chief Executive Officer | Sell | $84K (8,400 @ $10.03) |
| Jun 9, 2025 | Michel Detheux | Chief Executive Officer | Sell | $440K (43,882 @ $10.03) |
| Jun 6, 2025 | David Hallal | Insider | Sell | $391K (38,228 @ $10.24) |
| Jun 6, 2025 | Michel Detheux | Chief Executive Officer | Sell | $86K (8,400 @ $10.21) |
| Jun 6, 2025 | Michel Detheux | Chief Executive Officer | Sell | $448K (43,882 @ $10.21) |
| Jun 5, 2025 | Michel Detheux | Chief Executive Officer | Sell | $85K (8,400 @ $10.15) |
| Jun 5, 2025 | Michel Detheux | Chief Executive Officer | Sell | $445K (43,882 @ $10.15) |
| Jun 5, 2025 | David Hallal | Insider | Sell | $388K (38,227 @ $10.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.